hrcak mascot   Srce   HID

Izvorni znanstveni članak
https://doi.org/10.2478/acph-2021-0008

An analytical “quality by design” approach in RP-HPLC method development and validation for reliable and rapid estimation of irinotecan in an injectable formulation

NAVYA AJITKUMAR BHASKARAN ; Department of Pharmaceutics, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal 576104, Udupi, Karnataka, India
LALIT KUMAR   ORCID icon orcid.org/0000-0002-2418-9712 ; Department of Pharmaceutics, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal 576104, Udupi, Karnataka, India
M SREENIVASA REDDY ; Department of Pharmaceutics, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal 576104, Udupi, Karnataka, India
GIRISH PAI K ; Department of Pharmaceutics, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal 576104, Udupi, Karnataka, India

Puni tekst: engleski, pdf (658 KB) str. 57-79 preuzimanja: 105* citiraj
APA 6th Edition
AJITKUMAR BHASKARAN, N., KUMAR, L., REDDY, M.S. i PAI K, G. (2021). An analytical “quality by design” approach in RP-HPLC method development and validation for reliable and rapid estimation of irinotecan in an injectable formulation. Acta Pharmaceutica, 71 (1), 57-79. https://doi.org/10.2478/acph-2021-0008
MLA 8th Edition
AJITKUMAR BHASKARAN, NAVYA, et al. "An analytical “quality by design” approach in RP-HPLC method development and validation for reliable and rapid estimation of irinotecan in an injectable formulation." Acta Pharmaceutica, vol. 71, br. 1, 2021, str. 57-79. https://doi.org/10.2478/acph-2021-0008. Citirano 02.12.2020.
Chicago 17th Edition
AJITKUMAR BHASKARAN, NAVYA, LALIT KUMAR, M SREENIVASA REDDY i GIRISH PAI K. "An analytical “quality by design” approach in RP-HPLC method development and validation for reliable and rapid estimation of irinotecan in an injectable formulation." Acta Pharmaceutica 71, br. 1 (2021): 57-79. https://doi.org/10.2478/acph-2021-0008
Harvard
AJITKUMAR BHASKARAN, N., et al. (2021). 'An analytical “quality by design” approach in RP-HPLC method development and validation for reliable and rapid estimation of irinotecan in an injectable formulation', Acta Pharmaceutica, 71(1), str. 57-79. https://doi.org/10.2478/acph-2021-0008
Vancouver
AJITKUMAR BHASKARAN N, KUMAR L, REDDY MS, PAI K G. An analytical “quality by design” approach in RP-HPLC method development and validation for reliable and rapid estimation of irinotecan in an injectable formulation. Acta Pharm. [Internet]. 2021 [pristupljeno 02.12.2020.];71(1):57-79. https://doi.org/10.2478/acph-2021-0008
IEEE
N. AJITKUMAR BHASKARAN, L. KUMAR, M.S. REDDY i G. PAI K, "An analytical “quality by design” approach in RP-HPLC method development and validation for reliable and rapid estimation of irinotecan in an injectable formulation", Acta Pharmaceutica, vol.71, br. 1, str. 57-79, 2021. [Online]. https://doi.org/10.2478/acph-2021-0008

Sažetak
The objective of the present study was to develop a robust, simple, economical and sensitive HPLC-UV method using the “quality-by-design” approach for the estimation of irinotecan (IRI) in marketed formulations. RP-HPLC method was developed by applying Box-Behnken design with HyperClone (Phenomenex®) C18 column (250 × 4.6 mm id, particle size 5 µm, ODS 130 Å) as a stationary phase. Acetonitrile and 20 mmol L–1 potassium phosphate buffer (pH 2.5) containing 0.1 % triethylamine in a ratio of 45:55 % (V/V) was used as a mobile phase. The sample was injected in a volume of 20 µL into the HPLC system. UV detector at 254 nm was used to estimate and quantify IRI. Isocratic elution was opted while the flow rate was maintained at 0.75 mL min–1. The retention time of IRI was found to be 4.09 min. The responses were found to be linear for concentration range of 0.5 to 18.0 µg mL–1 and the coefficient of determination value was found to be 0.9993. Percent relative standard deviation for intra- and inter-day precisions was found in the range of 0.1 to 0.4 %. LOD and LOQ values were found to be 4.87 and 14.75 ng mL–1, resp. Robustness studies confirmed that the developed method is robust with RSD of a maximum 0.1 %. The method is simple, precise, sensitive, robust and economical making it applicable to the estimation of IRI in an injectable formulation.

Ključne riječi
irinotecan; HPLC-UV; “quality by design”; full factorial design; Box-Behnken design

Hrčak ID: 236804

URI
https://hrcak.srce.hr/236804

Posjeta: 198 *